U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 147

1.
Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer
Chenxi Niu, Haixuan Wen, Shutong Wang, Guang Shu, Maonan Wang, Hanxi Yi, Ke Guo, Qiong Pan, Gang Yin
Aging (Albany NY) 2024 Jan 31; 16(2): 1021–1048. Published online 2024 Jan 23. doi: 10.18632/aging.205225
PMCID:
PMC10866441
ArticlePDF–4.7M
2.
Structural basis for specific DNA sequence motif recognition by the TFAP2 transcription factors
Ke Liu, Yuqing Xiao, Linyao Gan, Weifang Li, Jin Zhang, Jinrong Min
Nucleic Acids Res. 2023 Aug 25; 51(15): 8270–8282. Published online 2023 Jul 6. doi: 10.1093/nar/gkad583
PMCID:
PMC10450164
ArticlePDF–1.6M
3.
Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression
Shengwen Long, Guixiang Huang, Mi Ouyang, Kai Xiao, Hao Zhou, Anyi Hou, Zhiwei Li, Zhe Zhong, Dongmei Zhong, Qinghao Wang, Shuanglin Xiang, Xiaofeng Ding
Cell Death Dis. 2023 Jun; 14(6): 365. Published online 2023 Jun 17. doi: 10.1038/s41419-023-05878-x
PMCID:
PMC10276877
ArticlePDF–6.1M
4.
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1
Junyuan Yang, Yang Gao, Sinjie Yao, Shimeng Wan, Hongbing Cai
Oncol Rep. 2023 Jun; 49(6): 114. Published online 2023 Apr 20. doi: 10.3892/or.2023.8551
PMCID:
PMC10170487
ArticlePDF–13M
5.
Transcription factor AP-2α activates RNA polymerase III–directed transcription and tumor cell proliferation by controlling expression of c-MYC and p53
Juan Wang, Qiyue Chen, Feixia Peng, Shasha Zhao, Cheng Zhang, Xiaoye Song, Deen Yu, Zhongyu Wu, Jiannan Du, Hongwei Ni, Huan Deng, Wensheng Deng
J Biol Chem. 2023 Mar; 299(3): 102945. Published online 2023 Jan 25. doi: 10.1016/j.jbc.2023.102945
PMCID:
PMC9999235
ArticlePDF–1.9M
6.
Family based and case–control designs reveal an association of TFAP2A in nonsyndromic cleft lip only among Vietnamese population
Duc Minh Nguyen, Satoshi Suzuki, Hideto Imura, Teruyuki Niimi, Hiroo Furukawa, Thanh‐Van Ta, Son Minh Tong, Tra Thu Nguyen, Loc Nguyen Gia Pham, Duy Le Tran, Nagato Natsume
Mol Genet Genomic Med. 2021 Sep; 9(9): e1754. Published online 2021 Jul 26. doi: 10.1002/mgg3.1754
PMCID:
PMC8457689
ArticlePDF–488K
7.
AP-2α Regulates S-phase and is a Marker for Sensitivity to PI3K-inhibitor Buparlisib in Colon Cancer
Anna C. Beck, Edward Cho, Jeffrey R. White, Lily Paemka, Tiandao Li, Vivian W. Gu, Dakota T. Thompson, Kelsey E. Koch, Christopher Franke, Matthew Gosse, Vincent T. Wu, Shannon R. Landers, Anthony J Pamatmat, Mikhail V. Kulak, Ronald J. Weigel
Mol Cancer Res. Author manuscript; available in PMC 2022 Jan 1.
Published in final edited form as: Mol Cancer Res. 2021 Jul; 19(7): 1156–1167. Published online 2021 Mar 22. doi: 10.1158/1541-7786.MCR-20-0867
PMCID:
PMC8254761
ArticlePDF–1.8M
8.
Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell lines
Luciane T. Kagohara, Fernando Zamuner, Emily F. Davis-Marcisak, Gaurav Sharma, Michael Considine, Jawara Allen, Srinivasan Yegnasubramanian, Daria A. Gaykalova, Elana J. Fertig
Br J Cancer. 2020 Jul 7; 123(1): 101–113. Published online 2020 May 4. doi: 10.1038/s41416-020-0851-5
Correction in:
Br J Cancer. 2020 Nov 10; 123(10): 1582–1583.
PMCID:
PMC7341752
ArticlePDF–2.3M
9.
AP2a enhanced the osteogenic differentiation of mesenchymal stem cells by inhibiting the formation of YAP/RUNX2 complex and BARX1 transcription
Xiao Lin, Haoqing Yang, Lijun Wang, Wenzhi Li, Shu Diao, Juan Du, Songlin Wang, Rui Dong, Jun Li, Zhipeng Fan
Cell Prolif. 2019 Jan; 52(1): e12522. Published online 2018 Nov 15. doi: 10.1111/cpr.12522
PMCID:
PMC6430486
ArticlePDF–1011K
10.
Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma
Andrea R Hallberg, Sabine U Vorrink, Danielle R Hudachek, Kimberly Cramer-Morales, Mohammed M Milhem, Robert A Cornell, Frederick E Domann
Epigenetics. 2014 Dec; 9(12): 1641–1647. Published online 2015 Jan 27. doi: 10.4161/15592294.2014.988062
PMCID:
PMC4622677
ArticlePDF–525K
11.
Ectopic expression of AP-2α transcription factor suppresses glioma progression
Wenjing Su, Juan Xia, Xueqin Chen, Miao Xu, Ling Nie, Ni Chen, Jing Gong, Xinglan Li, Qiao Zhou
Int J Clin Exp Pathol. 2014; 7(12): 8666–8674. Published online 2014 Nov 26.
PMCID:
PMC4314016
ArticlePDF–1.2M
12.
Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domain
Hong Li, Ryan Sheridan, Trevor Williams
Hum Mol Genet. 2013 Aug 15; 22(16): 3195–3206. Published online 2013 Apr 10. doi: 10.1093/hmg/ddt173
PMCID:
PMC3723307
ArticlePDF–625K
13.
Abnormal expression of transcription factor AP-2α in pathologic placentas
Rachel M. Sheridan, Jerzy Stanek, Jane Khoury, Stuart Handwerger
Hum Pathol. Author manuscript; available in PMC 2013 Nov 1.
Published in final edited form as: Hum Pathol. 2012 Nov; 43(11): 1866–1874. Published online 2012 May 9. doi: 10.1016/j.humpath.2012.01.011
PMCID:
PMC3433582
ArticlePDF–1.8M
14.
Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells
Peter B. Makhov, Konstantin V. Golovine, Alexander Kutikov, Daniel J. Canter, Vera A. Rybko, Dmitry A. Roshchin, Vsevolod B. Matveev, Robert G. Uzzo, Vladimir M. Kolenko
Carcinogenesis. 2011 Dec; 32(12): 1773–1781. Published online 2011 Sep 22. doi: 10.1093/carcin/bgr212
PMCID:
PMC3220607
ArticlePDF–833K
15.
Alternative TFAP2A isoforms have distinct activities in breast cancer
Chiara Berlato, KaYi V Chan, Anna M Price, Monica Canosa, Angelo G Scibetta, Helen C Hurst
Breast Cancer Res. 2011; 13(2): R23. Published online 2011 Mar 4. doi: 10.1186/bcr2838
PMCID:
PMC3219183
ArticlePDF–772K
16.
Reduced Expression of Transcription Factor AP-2α Is Associated with Gastric Adenocarcinoma Prognosis
Wei Wang, Lin Lv, Ke Pan, Yu Zhang, Jing-jing Zhao, Ju-gao Chen, Yi-bing Chen, Yong-qiang Li, Qi-jin Wang, Jia He, Shi-ping Chen, Zhi-wei Zhou, Jian-chuan Xia
PLoS One. 2011; 6(9): e24897. Published online 2011 Sep 26. doi: 10.1371/journal.pone.0024897
PMCID:
PMC3180284
ArticlePDF–437K
17.
Protein-Binding Microarray Analysis of Tumor Suppressor AP2α Target Gene Specificity
Jan Kerschgens, Stéphanie Renaud, Frédéric Schütz, Luigino Grasso, Tanja Egener-Kuhn, Jean-François Delaloye, Hans-Anton Lehr, Horst Vogel, Nicolas Mermod
PLoS One. 2011; 6(8): e22895. Published online 2011 Aug 18. doi: 10.1371/journal.pone.0022895
PMCID:
PMC3158074
ArticlePDF–1.0M
18.
Aberrant expressions of AP-2α splice variants in pancreatic cancer
Catherine Carrière, Sarah Mirocha, Sophie Deharvengt, Jason R. Gunn, Murray Korc
Pancreas. Author manuscript; available in PMC 2012 Jul 1.
Published in final edited form as: Pancreas. 2011 Jul; 40(5): 695–700. doi: 10.1097/MPA.0b013e31821f2715
PMCID:
PMC3116516
ArticlePDF–486K
19.
Frontal nasal prominence expression driven by Tcfap2a relies on a conserved binding site for STAT proteins
Amy L. Donner, Trevor Williams
Dev Dyn. Author manuscript; available in PMC 2009 Sep 4.
Published in final edited form as: Dev Dyn. 2006 May; 235(5): 1358–1370. doi: 10.1002/dvdy.20722
PMCID:
PMC2738421
ArticlePDF–1.0M
20.
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression
N Jonckheere, V Fauquette, L Stechly, N Saint-Laurent, S Aubert, C Susini, G Huet, N Porchet, I Van Seuningen, P Pigny
Br J Cancer. 2009 Aug 18; 101(4): 637–644. Published online 2009 Aug 11. doi: 10.1038/sj.bjc.6605190
PMCID:
PMC2736821
ArticlePDF–428K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center